Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Serum Anti-Mullerian Hormone (AMH) and Inhibin B Levels as Early Predictors of a Successful IVF Cycle in Women Over 38 Years Old.

NCT01219387 is registered in ClinicalTrials.gov with Reproductive Medicine Associates of New Jersey as lead sponsor.

NCT NCT01219387
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01219387 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Serum Anti-Mullerian Hormone (AMH) and Inhibin B Levels as Early Predictors of a Successful IVF Cycle in Women Over 38 Years Old.
Lead sponsor
Reproductive Medicine Associates of New Jersey
Phase
Observational
Overall status
Completed
Start date
February 28, 2006
Completion date
June 30, 2010
Enrollment
300 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

amh levels, inhibin b levels, ivf patients over 38 years old